ABT
Abbott Laboratories
Abbott Laboratories is a diversified healthcare company with significant federal contract exposure ($660M in obligations) and a strong structural political alignment with the House Energy and Commerce Committee, evidenced by $10K donations to 6 of its members.
Govt Dependence
65/100
Regulatory Density
85/100
Lobbying Intensity
40/100
Political Signal
BULLISH
BusinessWhat ABT does
Abbott Laboratories operates as a global healthcare company with diversified revenue lines including medical devices (e.g., continuous glucose monitors), diagnostics, nutrition, and branded generic pharmaceuticals. Its business model relies on product innovation, regulatory approvals, and reimbursement policies from government health programs. Federal contracts, primarily with the Department of Health and Human Services and the Department of Veterans Affairs, represent a material revenue stream.
6 months past · 3 months futureABT activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
113 trading days ·
15 congressional trades shown
·
3 insider buys
·
4 13F filings
·
0 past bill actions
·
16 upcoming markups
Executive Branch ConflictsABT held by Trump-administration officials
2 cabinet/senior officials reported ABT positions in OGE Form 278 disclosures across 6 filings.
Donald J. Trump
President · White House
Abbott Laboratories
Donald J. Trump
President · White House
ABBOTT LABS
Donald J. Trump
President · White House
Abbott Laboratories
Donald J. Trump
President · White House
Abbott Labs
Donald J. Trump
President · White House
Abbott Laboratories
Jamieson Greer
U.S. Trade Representative · Office of the USTR
Abbott Laboratories
Lifetime Government AwardsABT federal contracts by year
$660M
total awarded · 2014–2026
449
contracts on file
2022
peak year ($128M)
Top contracts by award amount
$65.5M
Department of Health and Human Serv
2022-09-21
ABBOTT: TO CONDUCT CLINICAL TRAINING AND VALIDATION STUDIES TO SUPPORT
$37.6M
Department of Defense
2019-03-01
LABORATORY ASSAY FOR TRAUMATIC BRAIN INJURY
$13.5M
Department of Defense
2017-04-25
IGF::CT::IGF COMPLETE CONCEPT PERFORMANCE EVALUATION
$12.1M
Department of Veterans Affairs
2018-10-18
IGF::OT::IGF CHEMISTRY ANALYZERS/AUTOMATION COST-PER-REPORTABLE RHJ VA
$11.4M
Department of Veterans Affairs
2024-04-01
VISN 9 CHEMISTRY AUTOMATION COST PER RESULTS REPORTABLE
13 years · 449 contracts
Smart Money · 13F HoldingsHedge funds holding ABT
$4.87B
Total ABT held by tracked 13F funds
40
Funds with ABT positions
+40
Funds opened this quarter
Citadel Advisors
$350M
opened
2024-12-31
Citadel Advisors
$308M
opened
17 overlap
2025-12-31
Citadel Advisors
$288M
opened
2025-06-30
Citadel Advisors
$288M
opened
2025-03-31
Citadel Advisors
$251M
opened
2025-09-30
Two Sigma Investments
$247M
opened
2024-06-30
Millennium Management
$242M
opened
2024-06-30
Citadel Advisors
$223M
opened
2024-06-30
32 more 13F positions tracked · quarterly delta charts available in member dashboard
Politicians Trading ABTMembers of Congress with recent ABT positions
19 politicians traded ABT across 109 disclosed transactions totaling $1.9M (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just ABT). 0-30 LOW · 30-60 MID · 60+ HIGH.
Michael T. McCaul
8 buys
9 sells
$819K
2026-03-04
LOW · 0
Ro Khanna
14 buys
16 sells
$363K
2026-01-29
LOW · 0
Jefferson Shreve
2 sells
$150K
2025-05-12
LOW · 0
Josh Gottheimer
10 buys
4 sells
$112K
2025-07-18
LOW · 1
Markwayne Mullin
4 sells
$81K
2025-01-08
LOW · 29
Thomas H. Kean
7 buys
$56K
2026-01-29
LOW · 2
Lisa C. McClain
2 buys
2 sells
$32K
2025-07-10
LOW · 0
Jared Moskowitz
2 buys
2 sells
$32K
2025-01-15
LOW · 0
Julie Johnson
4 sells
$32K
2025-12-18
LOW · 15
Bruce Westerman
2 buys
2 sells
$32K
2025-04-21
LOW · 0
Gilbert Ray Cisneros
1 buy
2 sells
$24K
2026-02-10
HIGH · 61
Byron Donalds
2 buys
1 sell
$24K
2025-12-04
LOW · 1
Rick Larsen
2 buys
$16K
2025-10-06
LOW · 2
John James
2 sells
$16K
2024-09-04
LOW · 0
Shelley Moore Capito
2 sells
$16K
2025-02-24
LOW · 12
4 more politicians active in ABT · full table in member dashboard
Congressional TradesWho in Congress is trading ABT
2026-03-24
Laura Friedman
Exchange
$1,001 - $15,000
2026-03-04
Michael T. McCaul
Sale
$1,001 - $15,000
2026-03-19
Richard McCormick
Purchase
$1,001 - $15,000
2026-02-10
Gilbert Ray Cisneros
Sale
$1,001 - $15,000
2026-01-29
Thomas H. Kean
Purchase
$1,001 - $15,000
2026-01-22
Ro Khanna
Sale
$15,001 - $50,000
2026-01-22
Ro Khanna
Sale
$1,001 - $15,000
2026-01-29
Ro Khanna
Sale
$15,001 - $50,000
2026-01-23
Ro Khanna
Sale
$15,001 - $50,000
2025-12-18
Julie Johnson
Sale
$1,001 - $15,000
2025-12-08
Julia Letlow
Sale
$1,001 - $15,000
2024-10-23
Julia Letlow
Purchase
$1,001 - $15,000
447d late
30+ trades on file · most recent 2026-04-17
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Open-market buys
S
Insider signal score 70/100 · 4 distinct insiders · 8 open-market buys totaling $8.8M in the last 180 days.
2026-01-23
Ford Robert B
CHAIRMAN AND CEO
BUY
18,800 sh
$2.0M
Stock awards & option exercises
42
stock awards · $172.3M market value
2026-03-31
Stratton John G
Director
AWARD
382 sh
$39K
2026-03-31
Roman Michael F
Director
AWARD
367 sh
$38K
2026-03-31
Gonzalez Patricia Paola
Director
AWARD
321 sh
$33K
2026-03-31
Ahuja Nita
Director
AWARD
102 sh
$10K
2026-03-31
Alpern Robert J
Director
AWARD
76 sh
$8K
2026-03-23
ORVILLE JACOB A
Senior Vice President
AWARD
13,255 sh
$1.4M
2026-03-23
ORVILLE JACOB A
Senior Vice President
AWARD
13,255 sh
$1.4M
2026-03-23
ORVILLE JACOB A
Senior Vice President
AWARD
13,255 sh
$1.4M
For ABT, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.
Bills Affecting ABTLive legislation impacting this stock
HR.1860 · 119th
Women Veterans Cancer Care Coordination Act
HR.1875 · 119th
Medicaid Provider Screening Accountability Act
HR.1867 · 119th
To amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnish
HR.1843 · 119th
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
HRES.185 · 119th
Recognizing the need of Congress to prevent, address, and treat obesity as a disease in the United States on this World Obesity Da
HRES.182 · 119th
Expressing support for the designation of March 3, 2025, as "National Triple-Negative Breast Cancer Day".
S.786 · 119th
Public Health Funding Restoration Act
S.763 · 119th
Telehealth Expansion Act of 2025
HR.679 · 119th
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strate
S.574 · 118th
Increasing Prescription Drug Competition Act
Political ProfileWhere ABT sits in Washington
[object Object]
STRUCTURAL: Deep committee alignment with House Energy & Commerce (6 members donated $10K each) and lobbying focused on expanding CGM coverage in key agencies. EVIDENTIARY: Strong insider cluster buying ($8.76M total, CEO purchase of $2.01M) and two congressional traders (Foxx, Gottheimer) with net buys. Net: Structural access combined with bullish trading signals from corporate and political insiders.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Heightened scrutiny of physician payments under Sunshine ActCMS"`get_political_influence.doctor_payments` shows $38.2M in payments to 291,957 physicians in 2024."
Regulatory opportunities
-
Expanded coverage for continuous glucose monitors (CGM) in VA and military health systemsDepartment of Veterans Affairs, Department of Defense"Lobbying filings cite 'efforts to increase veterans' access to diabetes treatment options' and work with VA on CGM (`Lobbying filings touching this ticker`)."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
LobbyingWho's hired to advocate for ABT
MCDERMOTT+ LLC · $40K defense
Member intelligence layer
Live signals + predictions for ABT — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades ABT
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout ABT & political exposure
Does Abbott Laboratories (ABT) hold federal contracts?
Yes. Abbott Laboratories has 449 federal contract awards totaling $660,211,260, primarily from agencies including Department of Agriculture, Department of Defense, Department of Health and Human Services. See full contract list and amounts on this page.
Which Trump cabinet officials own ABT stock?
2 Trump cabinet members or senior White House staff have disclosed holdings in ABT on their OGE 278 financial disclosures, including Donald J. Trump, Jamieson Greer. See the Cabinet Conflicts panel for details.
Has Congress traded ABT stock?
511 congressional trades by 53 unique members of Congress, most recently on 2026-03-24. See the Congressional Trading panel for politician-by-politician breakdown.
What is ABT political risk profile?
Government dependence: 65/100. Lobbying intensity: 40/100. Political signal: bullish. Donor party split: R 50% / D 50%.
How does GovGreed track ABT political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. ABT data is updated daily from these official federal sources.